Back
Accenture Plc 10K Form
Buy
61
ACN
Accenture Plc
Last Price:
$269.37
Seasonality Move:
1.63%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-03-21 | 10Q | ACN/Accenture Plc Quarterly |
| 2023-12-19 | 10Q | ACN/Accenture Plc Quarterly |
| 2023-06-22 | 10Q | ACN/Accenture Plc Quarterly |
| 2023-03-23 | 10Q | ACN/Accenture Plc Quarterly |
| 2022-12-16 | 10Q | ACN/Accenture Plc Quarterly |
| 2022-06-23 | 10Q | ACN/Accenture Plc Quarterly |
Receive ACN News And Ratings
See the #1 stock for the next 7 days that we like better than ACN
ACN Financial Statistics
Sales & Book Value
| Annual Sales: | $69.7B |
|---|---|
| Cash Flow: | $3.8B |
| Price / Cash Flow: | 15.86 |
| Annual Sales: | $50.17 |
| Price / Book: | 5.42 |
Profitability
| EPS (TTM): | 12.15360 |
|---|---|
| Net Income (TTM): | $7.8B |
| Gross Margin: | $22.2B |
| Return on Equity: | 25.56% |
| Return on Assets: | 12.86% |
Accenture Plc Earnings Forecast
Key Accenture Plc Financial Ratios
-
The Gross Profit Margin over the past 26 years for ACN is 31.90%.
-
The Selling, General & Administrative Expenses for ACN have been equal to 16.35% of Gross Profit Margin.
-
The Research & Development expenses have been 1.17% of Revenue.
-
The Interest Expense is 2.92% of Operating Income.
-
The Net Earning history of ACN is 11.24% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 20 years.
Accenture Plc Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | IT Services |
| Sector: | Information Technology |
| Current Symbol: | ACN |
| CUSIP: | G1151C |
| Website: | accenture.com |
Debt
| Debt-to-Equity Ratio: | 0.26 |
|---|---|
| Current Ratio: | 1.42 |
| Quick Ratio: | 1.3 |
Price-to-Earnings
| Trailing P/E Ratio: | 22.45 |
|---|---|
| Forward P/E Ratio: | 18.26 |
ACN Technical Analysis vs Fundamental Analysis
Buy
61
Accenture Plc (ACN)
is a Buy
Is Accenture Plc a Buy or a Sell?
-
Accenture Plc stock is rated a BuyThe current Accenture Plc [ACN] share price is $272.85. The Score for ACN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.